Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K-J Chen
Intravitreal Triamcinolone Acetonide vs Bevacizumab for Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Related publications
Intravitreal Bevacizumab for the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Intravitreal Bevacizumab for Macular Oedema Secondary to Branch Retinal Vein Occlusion: More Data Required
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
The Comparison of Intravitreal Triamcinolone and Bevacizumab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion
Clinical Ophthalmology
Ophthalmology
Intravitreal Triamcinolone Acetonide Injection for Macular Edema Due to Central Retinal Vein Occlusion Persisting Despite Multiple Intravitreal Bevacizumab Injections
Journal of Ocular Pharmacology and Therapeutics
Ophthalmology
Pharmacology
Comparison Between Intravitreal Bevacizumab and Posterior Sub-Tenon Injection of Triamcinolone Acetonide in Macular Edema Secondary to Retinal Vein Occlusion
Clinical Ophthalmology
Ophthalmology
Intravitreal PRN Ranibizumab Treatment for Macular Edemadue to Branch Retinal Vein Occlusion
Turkish Journal of Medical Sciences
Medicine
Initial Dose of Three Monthly Intravitreal Injections Versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Clinical Evaluation of Intravitreal Triamcinolone Acetonide in Diabetic Macular Oedema
Scholars Journal of Applied Medical Sciences
Short Term Results After Single Dose Intravitreal Bevacizumab Treatment for Macular Edema Secondary to Central and Branch Retinal Vein Occlusions
Southern Clinics of Istanbul Eurasia
